<?xml version="1.0" encoding="UTF-8"?>
<p>Developed countries such as the USA and Canada have also made full use of compulsory licenses in the field of public health to maintain the national interests and solve public crises according to the Protocol Amending TRIPS. In October 2001, there was a nationwide anthrax scare in USA resulting in rising demands for ciprofloxacin (Cipro). Anecdotally, many health professionals believe that “it is not anthrax, but the price of the drugs for anthrax that caused the panic.” The US government was faced with a dilemma during the 2001 anthrax scare. The US government consistently supported intellectual property protection for large pharmaceutical companies. Therefore, issuing a compulsory license for Cipro was a controversial act. In the end, the US government used the threat of a compulsory license to force Bayer to significantly lower its price and thus saved $276 million [
 <xref ref-type="bibr" rid="CR23">23</xref>].
</p>
